Drug: INFLIXIMAB Injury: Orbital apex syndrome Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125297682 | INFLIXIMAB | Orbital apex syndrome | ROCHE | 73.00 YR | F | 0 | 20160725 | DK |
125711241 | INFLIXIMAB | Orbital apex syndrome | MYLAN | 0.00 | 0 | 20160719 | DK | |
125790752 | INFLIXIMAB | Orbital apex syndrome | SANDOZ | 73.00 YR | F | 0 | 20160902 | DK |
125857971 | INFLIXIMAB | Orbital apex syndrome | STRIDES | 0.00 | 0 | 20160725 | DK | |
126002703 | infliximab | Orbital apex syndrome | TEVA | 73.00 YR | F | 0 | 20160804 | DK |
126482231 | Infliximab | Orbital apex syndrome | CELLTRION | 0.00 | 0 | 20160812 | DK |
Total Records: 6 Number of Pages: 1